Bioregenx (BRGX) Non-Current Assets (2021 - 2026)

Bioregenx's Non-Current Assets history runs 6 years deep, the most recent figure standing at $146778.0 for Q1 2026.

• On a quarterly basis, Non-Current Assets fell 22.08% year-over-year to $146778.0 in Q1 2026; TTM through Mar 2026 was $2.1 million, a 93.98% decrease from a year earlier, with the FY2025 full-year figure at $159721.0, down 20.43% from the prior year.
• Non-Current Assets retreated to $146778.0 in Q1 2026 per BRGX's latest filing, from $159721.0 in the prior quarter.
• Across five years, Non-Current Assets topped out at $18.1 million in Q1 2024 and bottomed at $31640.0 in Q4 2023.
• The 5-year median for Non-Current Assets is $174041.5 (2025), against an average of $4.0 million.
• Across the five-year window, Non-Current Assets surged 51040.25% in 2024 and slumped 98.96% in 2025, its largest moves.
• Year by year, Non-Current Assets stood at $58473.0 in 2022, then sank by 45.89% to $31640.0 in 2023, then soared by 534.45% to $200739.0 in 2024, then decreased by 20.43% to $159721.0 in 2025, then retreated by 8.1% to $146778.0 in 2026.
• Per Business Quant, the three latest BRGX Non-Current Assets figures stand at $146778.0 (Q1 2026), $159721.0 (Q4 2025), and $894608.0 (Q3 2025).